Rankings
▼
Calendar
HRTX FY 2010 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$147M
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+3.2% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$10M
-763.6% margin
Net Income
-$7M
-564.6% margin
EPS (Diluted)
$-3.70
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$3M
Total Liabilities
$2M
Stockholders' Equity
$1M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$1M
+3.2%
Gross Profit
$1M
$1M
+3.2%
Operating Income
-$10M
-$10M
+3.0%
Net Income
-$7M
-$10M
+26.7%
← FY 2009
All Quarters
FY 2011 →